Testing effectiveness (Phase 2)Active Not RecruitingNCT07285694
What this trial is testing
AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)
Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Arsenal Biosciences, Inc. 190